Induction of Remission in Autoimmune Polyglandular Syndrome Type Three (APS III): An Old Drug With New Perspectives
Clinical Case Reports - United Kingdom
doi 10.1002/ccr3.1827
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 2, 2018
Authors
Publisher
Wiley